Associate Professor of Radiation Oncology, Massachusetts General Hospital
Radiation Oncology
Dr. Torunn Yock, MD
|
|
Give Review
Doctor Torunn Yock, MD is an expert in the field of Radiation Oncology. She went to Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1 in research and 12 in primary care medicine Torunn Yock is a published doctor. She has 58 papers published. The most current publication "Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study."
Publications
- Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
- Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors.
- Proton therapy for pediatric and adolescent esthesioneuroblastoma.
- Health-Related Quality of Life of Adolescent and Young Adult Survivors of Central Nervous System Tumors: Identifying Domains From a Survivor Perspective.
- Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children.
- A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study.
- Quality of life outcomes in proton and photon treated pediatric brain tumor survivors.
- Protons, the brainstem, and toxicity: Ingredients for an emerging dialectic.
- Preliminary Results of a Phase II Trial of Proton Radiotherapy for Pediatric Rhabdomyosarcoma.
- Proton Radiation Therapy for the Treatment of Retinoblastoma.
- Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas.
- The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric pa...
- Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
- Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients.
- Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy.
- Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma.
- Incidence of second malignancies among patients treated with proton versus photon radiation.
- Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study.
- Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemo...
- High-Risk Medulloblastoma: A Pediatric Oncology Group Randomized Trial of Chemotherapy Before or After Radiation Therapy (POG 9031).
- Delayed Diagnosis in Children with Intracranial Germ Cell Tumors.
- Relapse After Treatment of Pediatric Hodgkin Lymphoma: Outcome and Role of Surveillance After End of Therapy.
- Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implications.
- Early Clinical Outcomes Using Proton Radiation for Children With Central Nervous System Atypical Teratoid Rhabdoid Tumors.
- Radiation recall myositis in pediatric Ewing sarcoma.
- SU-E-T-258: Assessment of Radiation Induced Second Cancer Risks in Proton Therapy and IMRT for Organs inside the Main Radiation Field.
- The use of proton therapy in the treatment of benign or low-grade pediatric brain tumors.
- Proton radiotherapy for pediatric sarcoma.
- Proton Radiotherapy for Pediatric Ewing's Sarcoma: Initial Clinical Outcomes.
- Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma.
- Proton Radiotherapy for Parameningeal Rhabdomyosarcoma: Clinical Outcomes and Late Effects.
- Proton Radiotherapy for Pediatric Bladder/Prostate Rhabdomyosarcoma: Clinical Outcomes and Dosimetry Compared to Intensity-Modulated Radiation Therapy.
- In vivo proton beam range verification using spine MRI changes.
- Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes.
- Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
- Proton beam therapy following resection for childhood ependymoma.
- Radiation therapy for pediatric central nervous system tumors.
- Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer.
- A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
- Surveillance of craniopharyngioma cyst growth in children treated with proton radiotherapy.
- Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter.
- Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation.
- Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons.
- Sellar abnormalities in female first-degree relatives.
- Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas.
- Radiation dose to the lens during craniospinal irradiation-an improvement in proton radiotherapy technique.
- Case records of the Massachusetts General Hospital. Case 20-2007. An 11-year-old boy with a calcified mass in the nose.
- Physiologic and radiographic evidence of the distal edge of the proton beam in craniospinal irradiation.
- Changes in cerebral cortex of children treated for medulloblastoma.
- Platelet-derived growth factor receptor-beta in Gorham''s disease.
- Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children''s Oncology Group.
- Role of radiation therapy in pediatric cancer.
- Technology insight: Proton beam radiotherapy for treatment in pediatric brain tumors.
- Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.
- Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma.
- The effect of delaying radiation therapy for systemic chemotherapy on local-regional control in breast cancer.
- Long-term durability of PSA failure-free survival after radiotherapy for localized prostate cancer.
Schools
Harvard Medical School
Santa Clara Vly Med Center
Massachusetts Gen Hospital
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
Massachusetts General Hospital -
Harvard Medical School
Hospital
-
Emerson Hospital -
Massachusetts General Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Melin J. Khandekar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela Derobertis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela Derobertis, MD |
|
|
Dr. Benjamin P. Falit, MD |
|
|
Dr. Peter Mauch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David T. Miyamoto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore S. Hong, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Joseph A. Aronovitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yen-Lin E. Chen, MD |
|
|
Dr. Michele Albert, MD
This Doctor is OpenDoctor Recommended.
|